27705964|t|Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE epsilon4 Carriers in a Population of Southern India.
27705964|a|BACKGROUND: This study delineates the role of the interaction of apolipoprotein E (APOE) and MAPT alleles in contributing to disease risks of dementia in a southern Indian population. METHODS: A sample of 419 patients comprising Alzheimer's disease (AD; n = 156), mild cognitive impairment (MCI; n = 87), frontotemporal dementia (FTD; n = 127), vascular dementia (VD; n = 37), and dementia with Lewy bodies (DLB; n = 12) was analysed in comparison with a control group (n = 138). APOE genotyping and MAPT haplotyping were performed on all study subjects. RESULTS: Multivariate logistic regression analysis showed that variability on the APOE locus influenced the relative risk of dementia in the study population. The APOE epsilon4 allele increased the disease risk most significantly for AD (OR = 3.468, p < 0.0001) and MCI (OR = 2.901, p < 0.0001). The APOE epsilon2 allele remained protective for AD (OR = 0.205, p < 0.05). For FTD, VD, and DLB, the APOE epsilon4 allele was ineffectual in modulating disease risk. The MAPT H1 haplotype was not an overrepresented marker of neurodegenerative diseases. The H1H1 genotype had an additive effect in contributing to either disease risk in combination with the APOE epsilon4 allele or protection in combination with the APOE epsilon2 or epsilon3 allele. CONCLUSIONS: This study is a reappraisal of the strong association of APOE variability with AD in southern India when compared to other dementia groups, while the transcriptional differences between MAPT haplotypes have a limited role in Indian dementia patients.
27705964	21	25	MAPT	Gene	4137
27705964	50	58	Dementia	Disease	MESH:D003704
27705964	190	206	apolipoprotein E	Gene	348
27705964	208	212	APOE	Gene	348
27705964	218	222	MAPT	Gene	4137
27705964	267	275	dementia	Disease	MESH:D003704
27705964	334	342	patients	Species	9606
27705964	354	373	Alzheimer's disease	Disease	MESH:D000544
27705964	375	377	AD	Disease	MESH:D000544
27705964	394	414	cognitive impairment	Disease	MESH:D003072
27705964	416	419	MCI	Disease	MESH:D060825
27705964	430	453	frontotemporal dementia	Disease	MESH:D057180
27705964	455	458	FTD	Disease	MESH:D057180
27705964	470	487	vascular dementia	Disease	MESH:D015140
27705964	489	491	VD	Disease	MESH:D015140
27705964	506	531	dementia with Lewy bodies	Disease	MESH:D020961
27705964	533	536	DLB	Disease	MESH:D020961
27705964	605	609	APOE	Gene	348
27705964	625	629	MAPT	Gene	4137
27705964	762	766	APOE	Gene	348
27705964	805	813	dementia	Disease	MESH:D003704
27705964	914	916	AD	Disease	MESH:D000544
27705964	946	949	MCI	Disease	MESH:D060825
27705964	980	984	APOE	Gene	348
27705964	1025	1027	AD	Disease	MESH:D000544
27705964	1056	1059	FTD	Disease	MESH:D057180
27705964	1061	1063	VD	Disease	MESH:D015140
27705964	1069	1072	DLB	Disease	MESH:D020961
27705964	1147	1151	MAPT	Gene	4137
27705964	1202	1228	neurodegenerative diseases	Disease	MESH:D019636
27705964	1393	1397	APOE	Gene	348
27705964	1497	1501	APOE	Gene	348
27705964	1519	1521	AD	Disease	MESH:D000544
27705964	1563	1571	dementia	Disease	MESH:D003704
27705964	1626	1630	MAPT	Gene	4137
27705964	1672	1680	dementia	Disease	MESH:D003704
27705964	1681	1689	patients	Species	9606
27705964	Association	MESH:D003704	348
27705964	Association	MESH:D000544	348
27705964	Association	MESH:D003704	4137

